Indivior PLC Performance

IZQVFDelisted Stock  USD 23.94  0.35  1.44%   
The company retains a Market Volatility (i.e., Beta) of 0.13, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Indivior PLC's returns are expected to increase less than the market. However, during the bear market, the loss of holding Indivior PLC is expected to be smaller as well. Indivior PLC right now retains a risk of 0.0%. Please check out Indivior PLC value at risk, and the relationship between the jensen alpha and skewness , to decide if Indivior PLC will be following its current trending patterns.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Indivior PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Indivior PLC is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Begin Period Cash Flow858 M
Total Cashflows From Investing Activities-14 M
Free Cash Flow319 M
  

Indivior PLC Relative Risk vs. Return Landscape

If you would invest  2,394  in Indivior PLC on October 4, 2024 and sell it today you would earn a total of  0.00  from holding Indivior PLC or generate 0.0% return on investment over 90 days. Indivior PLC is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Indivior, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  

Indivior PLC Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Indivior PLC's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Indivior PLC, and traders can use it to determine the average amount a Indivior PLC's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
IZQVF
Based on monthly moving average Indivior PLC is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Indivior PLC by adding Indivior PLC to a well-diversified portfolio.

Indivior PLC Fundamentals Growth

Indivior Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Indivior PLC, and Indivior PLC fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Indivior Pink Sheet performance.

About Indivior PLC Performance

By analyzing Indivior PLC's fundamental ratios, stakeholders can gain valuable insights into Indivior PLC's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Indivior PLC has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Indivior PLC has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia. Indiviorplc operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 900 people.

Things to note about Indivior PLC performance evaluation

Checking the ongoing alerts about Indivior PLC for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Indivior PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Indivior PLC is not yet fully synchronised with the market data
Indivior PLC has a very high chance of going through financial distress in the upcoming years
About 62.0% of the company shares are owned by institutional investors
Evaluating Indivior PLC's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Indivior PLC's pink sheet performance include:
  • Analyzing Indivior PLC's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Indivior PLC's stock is overvalued or undervalued compared to its peers.
  • Examining Indivior PLC's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Indivior PLC's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Indivior PLC's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Indivior PLC's pink sheet. These opinions can provide insight into Indivior PLC's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Indivior PLC's pink sheet performance is not an exact science, and many factors can impact Indivior PLC's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Consideration for investing in Indivior Pink Sheet

If you are still planning to invest in Indivior PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Indivior PLC's history and understand the potential risks before investing.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance